User profiles for Esra K. Saglam

Esra Kaytan Saglam

Istanbul University
Verified email at istanbul.edu.tr
Cited by 1793

[HTML][HTML] Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study

S Saglam, D Bugra, EK Saglam, O Asoglu… - Journal of …, 2014 - ncbi.nlm.nih.gov
Background and purpose The optimum duration between neoadjuvant radiochemotherapy
and transmesorectal excision in locally advanced rectal cancer has not been defined yet. …

Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma

…, S Vatansever, EN Oral, EK Saglam… - Journal of …, 2016 - Taylor & Francis
Background: Non-HIV related Kaposi sarcoma (NHKS) is a rare indolent neoplasm which is
more common around Mediterranean origin. Data concerning factors that influence …

[PDF][PDF] Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?

…, Z Güral, EK Saglam, S Saglam… - Diagnostic and …, 2012 - cms.dirjournal.org
PURPOSE We aimed to prospectively determine if analyzing pre-and post-chemoradiotheraphy
(CRT) changes in the signal intensity (SI) and apperent diffusion coefficient (ADC) …

Effects of boron-based gel on radiation-induced dermatitis in breast cancer: a double-blind, placebo-controlled trial

E Aysan, UO Idiz, L Elmas, EK Saglam… - Journal of …, 2017 - Taylor & Francis
Aim: This study is aimed to evaluate the effects of boron on radiation-induced skin reactions
(RISR) in breast cancer patients. Material and methods: After 47 patients with invasive ductal …

Changes in radiotherapy practice during COVID-19 outbreak in Turkey: A report from the Turkish Society for Radiation Oncology

…, D Yalman, F Yıldız, EK Saglam - Radiotherapy and …, 2020 - thegreenjournal.com
COVID-19 outbreak forced significant changes in the management of non-communicable
diseases worldwide including cancer. The first COVID-19 case in Turkey was announced on …

[PDF][PDF] Treatment outcome and prognostic factors in non-metastatic esophageal carcinoma

EK Saglam, S Kilciksiz, N Ozseker, A Karadeniz… - Saudi medical …, 2007 - academia.edu
Objectives: To investigate the therapeutic outcome and prognostic factors in patients with
non-metastatic esophageal carcinoma. Methods: Between January 1989 and December 2003, …

[HTML][HTML] Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung …

…, ME Guveli, R Ciftci, B Ozkan, EN Oral, EK Saglam… - Medicine, 2016 - journals.lww.com
Presently, there is no consensus regarding which chemotherapy regimen is best to
administer with radiotherapy in patients with locally advanced non-small-cell lung cancer (LA-NSCLC…

Association of clinical and pathological variables with survival in thymoma

A Aydiner, A Toker, F Sen, E Bicakci, EK Saglam… - Medical Oncology, 2012 - Springer
Our aim was to evaluate clinical and pathological features in prognosis of thymoma patients
with particular emphasis on patients with myasthenia gravis (MG). From 1995 to 2010, 140 …

Breaking bad news to cancer patients and their families: Attitudes toward death among Turkish physicians and their communication styles

D Anuk, N Alçalar, EK Sağlam… - Journal of psychosocial …, 2022 - Taylor & Francis
Objectives: To investigate how Turkish oncologists’ attitudes toward death influence their
emotional states, outlooks, and communication styles when breaking bad news to cancer …

Matriks metalloproteinazlar ve akciğer kanseri

…, H ÇAMLICA, D DURANYILDIZ, EK SAĞLAM… - Türk Onkoloji …, 2006 - dergipark.org.tr
… Matriks metalloproteinazlar (MMP) yaklafl›k 28 enzimden oluflan, fizyolojik ve patolojik
doku y›k›m›nda önemli rol oynayan ekstrasellüler proteazlard›r. Matriks metalloproteinazlar, …